---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-004273"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2026-01-16T23:59:59+00:00"
generated_at: "2026-05-16T09:45:28.089035+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Tvardi Therapeutics posts updated corporate presentation on website

## Summary
- Presentation available on company website as of January 16, 2026.
- No financial or operational updates disclosed in the filing text.
- Exhibit 99.1 appears incomplete; content not fully available for review.

## SEC filing metadata
- accession: 0001104659-26-004273
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2026-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465926004273/0001104659-26-004273-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465926004273/tm263373d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-004273
- JSON: https://secwatch.observer/filing/0001104659-26-004273.json
- Plain text: https://secwatch.observer/filing/0001104659-26-004273.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.